Extravillous cytotrophoblast (EVCT) is responsible for trophoblast invasion, which is an important process during placentation. Dysregulation of the process is associated with a wide range of pregnancy complications. Adrenomedullin (ADM) is a polypeptide expressed most abundantly in first-trimester placentas. We hypothesized that ADM modulated the invasion of human EVCT. Our results showed that ADM enhanced invasion and migration but not proliferation in two EVCT cell lines, JEG-3 and TEV-1. Similar observation can also be obtained in primary EVCTs. JEG-3 and TEV-1 cells expressed ADM receptor components as demonstrated by immunostaining, Western blotting, and RT-PCR. The ADM antagonist ADM 22-52 (ADM C-terminal 22-52 amino acid fragment) suppressed ADM-induced invasion and migration, confirming that ADM exerted its biological effects through its classical receptors. The stimulatory effect of ADM on EVCT invasiveness was associated with induction (P , 0.05) of urokinase plasminogen activator (uPA) and nitric oxide synthase (NOS) expression and activity. Silencing of uPA by siRNA transfection abolished the stimulatory effect of ADM, suggesting that uPA is the key mediator for ADM-induced invasion. The involvement of NO in enhancing the invasion and biosynthesis of uPA in EVCT cell lines was confirmed by using pharmacological inhibitors of NOS and NO donors. ADM-mediated NO production also increased protein S-nitrosylation of JEG-3 cells. Snitrosylation activated uPA in vitro and induced a higher proteinase activity. These findings provide indications that ADM and its downstream NO signaling may play an important role in modulating human EVCT functions.
INTRODUCTION
Trophoblast invasion into the endometrium is crucial to placentation [1, 2] . After implantation, cytotrophoblasts differentiate into the villous cytotrophoblast and the extravillous cytotrophoblast (EVCT). The former fuse to form the multinucleated syncytiotrophoblast responsible for fetomaternal exchange and production of hormones. The latter form migratory cell columns that invade the endometrium [3] . EVCT invasion peaks at early pregnancy and declines thereafter [4] .
Invasion by EVCT involves cellular proliferation, attachment of the cells to and degradation of extracellular matrix, and migration through connective tissue [5] . In contrast to tumor invasion, EVCT invasion is spatially and temporally regulated and confined to the inner third of the myometrium [5] . Despite intensive research, the mechanisms controlling human EVCT invasion are poorly understood and are believed to be mediated by a delicate balance between stimulatory and inhibitory factors of both trophoblastic and uterine origins [6] . Abnormalities in these factors lead to inadequate invasion, as observed in miscarriage, pre-eclampsia, and intrauterine growth restriction, or excessive invasion, as in choriocarcinoma [7] [8] [9] .
Adrenomedullin (ADM) is a polypeptide and a member of the calcitonin/calcitonin gene-related peptide (CGRP)/amylin peptide family [10] . The amino acid sequence and structure of ADM are highly conserved in mammals. The functions of ADM are mediated through a G protein-coupled receptor system composed of two transmembrane components, the calcitonin receptor-like receptor (CRLR) and the receptor activity-modifying protein (RAMP). ADM binds to CRLR when it is coupled to RAMP2 or RAMP3. When CRLR couples to RAMP1, the resulting complex binds CGRP, although with lower affinity for ADM [11] . Nitric oxide (NO) partly mediates the downstream signaling of ADM actions [12] .
ADM and CRLR and/or RAMPs are widely expressed in human reproductive tissues including ovary, oviduct, endometrium, placenta, and testis [10] . Research with ADM-deficient mice [13] and infusion of the ADM receptor antagonist (ADM ; ADM C-terminal 22-52 amino acid fragment) administered to pregnant rats [14] have demonstrated the role of ADM in early placental development. Mice with genetically reduced ADM expression [13] or rats with ADM 22-52 treatment [14] had compromised fetal growth, trophoblast invasion, and placental development. These defects lead to a poor maternalfetal placental interface and are notably associated with preeclampsia in humans. However, the role of ADM in human placentation remains to be demonstrated.
In humans, the expression of ADM in trophoblasts and decidua are most abundant in the first trimester [15] [16] [17] [18] , consistent with the involvement of ADM in early placentation and fetal growth. The coincidental rise of placental ADM with the invasion of EVCT into the decidua in early pregnancy suggests a relationship between them. Most studies of ADM concentrate on its vasodilatory activity. There is no study of the action of ADM in human EVCT functions, and the role of ADM in early placentation is not known. We hypothesized that ADM modulated the invasion of human EVCT. Therefore, the first objective of this study was to determine the effect of ADM on the invasiveness, cell migration, and proliferation of two EVCT cell lines, JEG-3 and TEV-1, and primary EVCTs. The second objective was to investigate the mechanism of invasionmodulatory activity of ADM on human EVCTs.
MATERIALS AND METHODS

Cell Culture
JEG-3 (American Type Culture Collection) is a choriocarcinoma cell line with a repertoire of human leukocyte antigen molecules similar to EVCT [19] and is frequently used as model for the study of EVCT invasion [2, 20, 21] . The immortalized TEV-1 cell line is derived from a primary culture of first-trimester normal EVCT isolated from human placenta by transfection of the human papillomavirus pLXSN-E6/E7 open reading frames [22] . Both cell lines were cultured in Dulbecco modified Eagle medium (DMEM)/F12 medium (Gibco) containing 10% heat-inactivated fetal bovine serum (FBS; Gibco) and 1% penicillin and streptomycin in a humidified atmosphere of 5% CO 2 in air at 378C.
Primary EVCTs
The study protocol was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster. Placental villi were obtained from women who had undergone surgical termination of pregnancy due to psychosocial reasons. Human primary trophoblasts were isolated as described previously [23] with slight modification. Briefly, placental villi were removed from the surgical specimens, minced, and digested with 0.25% trypsin for 10 min with constant shaking. Single cells were obtained by filtration through 40-lm and 50-lm filters (BD Bioscience), followed by Lymphoprep (GE Healthcare) density gradient centrifugation. Isolated cells were then incubated in a culture dish for 20 min to remove adherent leukocytes. Nonadherent cells were seeded onto fibronectin-coated plates and incubated overnight, and the adherent EVCTs were collected for subsequent experiments.
Transwell Invasion Assay
The 24-well Matrigel invasion chamber (BD Bioscience) assay was used to study the invasiveness of JEG-3 cells, TEV-1 cells, and primary EVCTs as described previously [24] . Cells (5 3 10 5 cells/ml) suspended in serum-free medium were seeded into a cell culture insert. Medium with 10% FBS was added to the tissue culture well, and cells were allowed to invade the Matrigel basement membrane matrix for 24 h. Cells that had invaded through the matrix were stained with Cell Stain (Millipore) and lysed with 10% acetic acid for quantification at an absorbance of 595 nm, using a microplate reader. Results were expressed as the percentage of absorbance relative to that of the no-treatment control.
Cell Migration Assay
A 96-well cell migration assay (CytoSelect; Cell Biolabs) was used to measure cell migration according to the manufacturer's instructions. JEG-3 or TEV-1 cells (1 3 10 5 cells/ml) in cell culture insert that had migrated to the bottom surface of the polycarbonate membrane after 24 h of incubation were dislodged using the cell detachment solution provided with the assay kit, lysed, and quantified with GR dye (Cyquant), using a fluorescence plate reader with excitation at 480 nm and emission at 520 nm. Results were expressed as the percentage of fluorescence intensity relative to that of the no-treatment control.
Cell Proliferation Assay
A fluorometric cell proliferation assay kit (Cyquant NF; Invitrogen) was used to determine cell proliferation according to the manufacturer's WONG ET AL.
instructions. Briefly, 1 3 10 4 cells/100 ll were incubated for 12, 24, and 48 h in 96-well plates. The cellular DNA content at the end of the incubation was measured using GR dye (CyQuant) as described above.
Urokinase Plasminogen Activator Activity Assay
Spent medium (conditioned medium) after JEG-3 cell, TEV-1 cell, or primary EVCT culture (200 ll) was collected, and the quantitative urokinase activity assay kit (Merck) was used according to the manufacturer's instructions. Briefly, the kit measured the ability of urokinase to digest a synthetic substrate, glutaryl-Gly-Arg-7-amino-4-methylcoumarin (AMC). The amount of digested AMC was quantified fluorometrically by an ELISA plate reader with an excitation wavelength of 380 nm and an emission wavelength of 505 nm. Urokinase plasminogen activator (uPA) activity was expressed as the percentage of fluorescence intensity relative to that of no-treatment control. 
Determination of Intracellular Nitric Oxide Level
Determination of Protein S-Nitrosylation
S-nitrosylated protein was isolated with an S-nitrosylated protein detection assay kit (Cayman Chemical Co.) and streptavidin-bound agarose (Merck). The assay used a biotin-switch method to biotinylate the S-nitrosylated proteins. Briefly, cells (20 3 10 6 cells) were lysed, and the free thiol groups were blocked with a blocking reagent provided in the kit. S-nitrosothiols of proteins were reduced and covalently labeled with maleimide-biotin. Streptavidin-bound agarose was then used to capture the biotin-labeled proteins, which were separated by SDS-PAGE and visualized by silver staining.
Detection of ADM Receptor Components in EVCT Cell Lines
The QuickPrep RNA extraction kit (GE Healthcare) was used to extract total RNA, which was reverse transcribed with the use of the TaqMan reverse transcription reagent kit (Applied Biosystems) and multiscript reverse transcriptase. The resulting cDNA was subjected to RT-PCR for detection of expression of ADM receptor components by using the FastStart Taq DNA polymerase kit (Roche) and the specific primers shown in Supplemental Table  S1 (all supplemental data are available online at www.biolreprod.org). Thermal
FIG. 2.
Effects of different concentrations of ADM (0.01-100 nM) on invasion, motility, and proliferation of EVCTs. To confirm that ADM receptors mediated the observed effects, cells were treated with ADM in the presence of 203 ADM . Invasion was quantitatively determined by using the 24-well Matrigel invasion assay (BD Scientific) (A), motility was determined by using CytoSelect 96-well cell migration assay (B), and proliferation was determined by using Cyquant NF cell proliferation assay kit (C) of JEG-3 and TEV-1 cells upon ADM treatment (N ¼ 5). D) The effect of 10 nM ADM on the invasiveness of primary EVCTs. Original magnification 3100. All values are the percentage of changes relative to the control without treatment. *P , 0.05 in comparison to the absorbance/fluorescence intensity with the control without treatment. Original magnification 3100.
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cycling conditions included an activation step at 958C for 2 min, followed by 30 cycles of denaturation (958C for 30 sec), annealing (608C for 30 sec), and amplification (728C for 2 min). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 24 cycles of PCR amplification) was used as the positive control, and water was used as the negative control. PCR products were subjected to agarose gel electrophoresis, visualized under ultraviolet light, and quantified by ImageJ software (National Institutes of Health).
ADM receptor component proteins were detected by Western blot analysis. A protein extraction reagent (Cytobuster; Merck) was used to lyse 2.5 3 10 5 JEG-3 or TEV-1 cells in the presence of a protease inhibitor cocktail (Merck). Protein lysates (20 mg) were separated by SDS-PAGE and transferred to a polyvinyl difluoride membrane, followed by incubation with polyclonal antibodies against CRLR, RAMP1, RAMP2, or RAMP3 (Santa Cruz Biotechnology; or Abcam) overnight at 48C (see Supplemental Table S2 ). Bound antibodies were detected by horseradish peroxidase-linked secondary antibody (1:5000 dilution; GE Healthcare).
The presence of ADM receptor components were further confirmed by immunostaining. JEG-3 or TEV-1 cells were seeded in 24-well plates (5 3 10 4 cells/well) and cultured for 24 h. Cells were then washed with PBS and fixed in 4% paraformaldehyde for 30 min. After cells were washed, they were incubated with a 1:100 mixture of antibodies against CRLR, RAMP1, RAMP2, or RAMP3 (Santa Cruz Biotechnology) overnight at 48C (see Supplemental Table  S2 ). Bound antibodies were detected by using a solution of Alexa Fluor-555-conjugated secondary antibody (diluted 1:1000; Invitrogen). Omission of the primary antibodies was used as control.
Effect of ADM on the Functions of EVCT Cell Lines
JEG-3 cells, TEV-1 cells, or primary EVCTs were treated with ADM (Sigma) at concentrations of 0.01, 0.1, 1, 10, or 100 nM with or without 20-fold excess of ADM (Sigma) in culture medium for 24 h. Cells treated with PBS were used as control. Cell invasion, migration, proliferation, uPA activity, intracellular NO level, and S-nitrosylated protein level were determined as described above. Expression of matrix metalloproteinase 2 (MMP2), uPA, and NO synthase (NOS) were determined by RT-PCR (Supplemental Table S1 ) and Table S2 ) as described previously [24, 25] . Band intensities were calculated by densitometry, with normalization to the corresponding loading control (GADPH or a-tubulin, respectively) and expressed as the percentage of change relative to that of the no-treatment group.
Western blotting (Supplemental
Effect of uPA Silencing on Trophoblast uPA Level and ADMInduced Trophoblast Invasion
Expression of uPA in JEG-3 cells was silenced by uPA short interfering RNA (siRNA) transfection. Briefly, JEG-3 cells (2.5 3 10 5 cells/ml) were seeded into a 6-well plate for 24 h and transfected with uPA siRNA (20 nM) (siRNA reagent identifier: s10612) or control siRNA (siRNA with a sequence that does not target any gene; Ambion) by Lipofectamine 2000 reagent mixture in opti-MEM medium (Invitrogen) according to the manufacturer's instruction. After 9 h of incubation, the transfection mixture was replaced with fresh DMEM/F12 medium and incubated for another 39 h. The protein contents of uPA in the siRNA-transfected cells were analyzed by Western blotting as described above. To confirm the role of uPA on ADM-induced trophoblast invasion, JEG-3 cells transfected with uPA siRNA or control siRNA were treated with ADM (10 nM) for 24 h before their invasion capacity was determined as described above. Cells treated with PBS were used as a control.
Effect of NOS Inhibitors and NO Donors on the Biological Activities of ADM
The role of NO in the biological activities of ADM was determined by NOS inhibitors. JEG-3 cells were incubated for 24 h with ADM (10 nM) in the presence of NOS inhibitors (Merck) including N-G-nitro-L-arginine methyl ester (L-NAME, 1 mM) or N-G-monomethyl-L-arginine (L-NMMA, 500 lM). The invasiveness and levels of uPA expression and activity of the cells were then quantified. Results were confirmed by 24-h treatment with 100 lM NO donors, S-nitroso-glutathione (GSNO; Merck) or spermine-NONOate (SNN, Merck).
Effect of GSNO on uPA Activity
To demonstrate the effect of NO-mediated S-nitrosylation on activation of uPA, 50 lg of purified uPA from human urine (catalog number: ab92737; Abcam) was treated with GSNO (100 lM) for 1 h at 378C in 5 ml of culture medium. GSNO is a commonly used S-nitrosylating agent [26] [27] [28] . Levels of S-nitrosylated uPA and uPA activity were then determined as described above.
Data Analysis
For all experiments, the nonparametric rank sum test for comparisons of absorbance/fluorescence intensity or densitometric value was used to identify differences between groups. If data were normally distributed, a parametric Student t-test was used as the post-test. Data were analyzed with SigmaStat version 2.03 software (Jandel Scientific), with a P value of ,0.05 considered significant. All values were expressed as mean 6 SEM percentages of change relative to that of the control group.
RESULTS
EVCT Cell Lines Express ADM Receptor Components
RT-PCR indicated the presence of transcripts of ADM receptor components in the JEG-3 and TEV-1 cells (Fig. 1) . While CRLR and RAMP3 transcripts were found in the JEG-3 cells, CRLR, RAMP1, and RAMP2 were detected in the TEV-1 cells (Fig. 1A) . Results were confirmed by determination of their protein expression using Western blotting (Fig. 1B) and immunostaining (Fig. 1C) . Western blotting showed multiple bands suggesting the presence of nonspecific binding and/or degradation of the target protein. To validate these results, the experiment was repeated using another antibody with different epitope specificities. Similar conclusions were reached for the two antibodies (Supplemental Fig. S1 ).
ADM Stimulates EVCT Invasion and Motility
ADM at concentrations of 1 and 10 nM significantly increased the invasiveness (P , 0.05) of JEG-3 and TEV-1 cells in comparison to the control ( Fig. 2A ). An ADM concentration of 10 nM significantly stimulated the invasiveness of primary EVCT (Fig. 2D ). ADM at a concentration 10 nM also stimulated motilities of both cell lines (Fig. 2B) . These actions of ADM were completely blocked by administration of 203 human ADM . Concentrations of ADM used had no effect on proliferation of the EVCT cell lines (Fig. 2C ) and primary EVCTs (data not shown). ADM (20 and 200 nM) alone had no effect on EVCT invasion, motility, and proliferation (data not shown).
ADM Upregulates uPA Expression/Activity in EVCTs
ADM significantly (P , 0.05) increased uPA expression (Fig. 3A) and activity ( Fig. S2 ). The role of uPA in the stimulatory effect of ADM on JEG-3 cells invasiveness was confirmed by a uPA siRNA experiment. After knockdown of uPA, the uPA protein level in JEG-3 cells was significantly (P , 0.05) suppressed in comparison to that of control siRNA-transfected cells (Fig. 4A) in Western blot analysis. Transfection of control or uPA siRNA alone had no significant (control siRNA, P ¼ 0.316; uPA siRNA, P ¼ 0.077) effect on the invasiveness of JEG-3 cells (Fig. 4B) . ADM increased JEG-3 cell invasion (P , 0.05) in the control siRNAtransfected JEG-3 cells (Fig. 4B) . The stimulatory effect was abolished in uPA siRNA-transfected JEG-3 cells (Fig. 4B) . Lipofectamine treatment or transfection of control siRNA did not affect the uPA protein expression level in comparison to that of the no-treatment control (data not shown).
ADM Upregulates JEG-3 Cells Intracellular NO Level
ADM at the concentrations tested increased the intracellular NO level of the JEG-3 cells (Fig. 5A ) and primary EVCTs (Fig. 5B) . At 10 nM, the fluorescence intensity of JEG-3 cells and primary EVCTs increased rapidly to ;160% and ;150% of the control value, respectively, in the first 5 min of ADM treatment. The signal decreased thereafter, reached a plateau after 120 min, and was maintained at the plateau value for the rest of experimental period in JEG-3 cells (Fig. 5A) .
ADM Upregulates NOS Expression of JEG-3 Cells
RT-PCR and Western blot results demonstrated that endothelial NOS (eNOS) and inducible NOS (iNOS), but not neuronal NOS (nNOS), were expressed in JEG-3 cells (Supplemental Fig. S3 ). ADM at concentrations !1 nM significantly (P , 0.05) increased expression of both eNOS and iNOS in the cells in comparison to that in the control (Fig.  5C ). At 10 nM of ADM treatment, the mean 6 SEM expression levels of eNOS and iNOS were enhanced by 36.4% 6 5.3% and 103.4% 6 10.4%, respectively. 
Effect of NOS Inhibitors and NO Donors on JEG-3 Cell Invasion
All NOS inhibitors significantly (P , 0.05) suppressed ADM-induced invasion in JEG-3 cells (Fig. 6A and Supplemental Fig. S4A) . Consistently, the inclusion of NOS inhibitor abolished the stimulatory effect of ADM on uPA expression ( Fig. 6A and Supplemental Fig. S4B) and activity (Fig. 6A) . The possible role of NO on the stimulatory activities of ADM on JEG-3 cells invasion was further supported by the study using NO donors. Both GSNO and SNN mimicked the biological activities of ADM by significantly (P , 0.05) increased invasiveness ( Fig. 6B and Supplemental Fig. S5A ), uPA expression (Fig. 6B and Supplemental Fig. S5B ), and activity (Fig. 6B ) of JEG-3 cells.
ADM Upregulates Protein S-Nitrosylation in JEG-3 Cells
Emerging evidence demonstrates that NOS or chemical NO donors such as GSNO affect protein function by S-nitrosylation [29] . ADM treatment increased the total S-nitrosylated protein level in the JEG-3 cells (Fig. 7A) , as measured by the biotinswitch method. To determine the role of S-nitrosylation of uPA in cell invasion of JEG-3, we examined the S-nitrosylation content of endogenous uPA after incubation with ADM. A minimal level of endogenous S-nitrosylated uPA was detected in the JEG-3 cells. Treatment with ADM induced a rapid (;5-min) and significant increase in S-nitrosylated uPA (Fig. 7B) . The specificity of the stimulatory effect of ADM was confirmed by treating the cells with ADM in the absence or presence of 203 human ADM for 24 h before the determination of S-nitrosylated uPA level. Inclusion of ADM completely blocked ADM-induced S-nitrosylated uPA production (Fig. 7C) .
To determine whether S-nitrosylation could activate uPA, we incubated uPA from urine with GSNO. In contrast to JEG-3 cell lysate, which contained the 55-kDa pro-uPA, purified uPA from human urine contained mainly the 33-kDa cleaved product of pro-uPA (Fig. 8 ) [30] . GSNO treatment increased the level of S-nitrosylated uPA (Fig. 8) and uPA activity significantly (P , 0.05) (Fig. 8) .
DISCUSSION
Two placental cell lines, JAr and HTR-8/SV neo, have been reported to possess ADM receptor components [15, 31] . By using the EVCT cell lines JEG-3 [19] and TEV-1 [22, 32] , we provided further evidence that ADM acts on JEG-3 and TEV-1 cells via its classical ADM receptor, using the specific ADM receptor antagonist ADM . Expression of CRLR and RAMPs was also shown by RT-PCR, Western blotting, and immunostaining. While both TEV-1 and JEG-3 cells expressed CRLR, their RAMP components were different. It has been shown that the gene expression of the RAMPs varies under histopathological conditions [11] ; RAMP2 is downregulated in lung tumor tissues in comparison to that in normal lung tissues [33] . Thus, the difference in the expression of RAMPs in the two cell lines studied may be the result of their cellular origins; JEG-3 cells are derived from choriocarcinoma, while TEV-1 cells originated from normal EVCT.
ADM and its receptor is highly expressed in human decidual cells [17, 18] and EVCT [15, 18] during early pregnancy. The conditioned medium of human decidual cells modulates the invasion of trophoblasts [34] . Apart from ADM, human decidual cells also secrete other regulatory factors during early pregnancy such as epidermal growth factor [35] , which has been shown to stimulate trophoblastic invasion [36] and ADM production [37] . The coincidental rise of placental ADM with the invasion of EVCT into the decidua in the first trimester of pregnancy are consistent with a role of ADM in regulating EVCT invasion. ADM increases the invasion of JAr and HTR-8/SV neo cells [31] . In this study, we further demonstrated that ADM increased the invasiveness and migration of EVCT cell lines or primary EVCTs. In contrast to HTR-8/SV neo and JAr cells, ADM has no effect on the proliferation of EVCTs. Indeed, invasive EVCTs are nonproliferating cells in vivo and depend on the EVCT progenitors proximal to villi for growth and renewal [38, 39] .
EVCT invasion is associated with degradation of the extracellular matrix of the decidual tissue. Members of the MMP and the uPA systems are the key enzymes involved in matrix degradation [40, 41] . The present study showed that ADM had no effect on the expression of MMP2 in TEV-1 and FIG. 6. Effect of NOS inhibitors or NO donors on JEG-3 invasiveness and uPA expression/activity. JEG-3 cell invasion, uPA expression, and uPA activity were determined after ADM with/without NOS inhibitor (A) or NO donor treatment (N ¼ 5) (B). JEG-3 invasion, uPA expression, and uPA activity were determined by using the 24-well Matrigel invasion assay (BD), RT-PCR analysis, and urokinase activity assay kit, respectively. Band intensities were calculated by densitometry (N ¼ 3), with normalization to the corresponding GADPH. All values are the percentage of changes relative to the control without treatment. *P , 0.05 in comparison to the absorbance/fluorescence intensity or densitometric value of the control without treatment.
# P , 0.05 in comparison to the absorbance/ fluorescence intensity or densitometric value of ADM treatment alone.
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JEG-3 cells. uPA is secreted as an inactive precursor and is activated by plasmin cleavage upon binding to the membranebound uPA receptor [40] . Trophoblasts express both uPA and its receptor uPAR [40] . Our results showed that ADM stimulated EVCT invasion by increasing the expression/ activity of uPA. Many placental factors such as gonadotropin-releasing hormone I and II [42] and glycodelin-A [24] have also been reported to modulate trophoblast invasion via regulation of uPA expression. In addition to cell invasion, the increase in uPA expression might also mediate the observed ADM-induced cell migration because the binding of the aminoterminal fragment of uPA to the cell surface uPAR induces release of migration-promoting signals in EVCT [43] . The exact mechanism of action of ADM on EVCT migration remains to be investigated.
The biological function of ADM in many cell types is mediated by NO induction [10, 44] . NO is a small diffusible signaling molecule regulating a diverse range of cellular processes, including implantation and pregnancy [45, 46] . NOS generates NO from L-arginine. Inhibition of NOS activity in early pregnancy markedly reduces placental size and causes intrauterine growth retardation in rats [47, 48] . Our results support earlier reports showing expression of eNOS and iNOS but not nNOS in EVCT [49] [50] [51] . Interestingly, the NOS activity in human placenta decreases with the placental ADM level from early pregnancy to late pregnancy or term [52] [53] [54] [55] , prompting the possibility of a relationship between NOS and ADM in early pregnancy. Indeed, the present study demonstrates that ADM stimulates JEG-3 and TEV-1 cell invasion by inducing NOS expression and subsequently NO production, consistent with the inhibitory action of NOS inhibitors on the ADM-mediated upregulation of invasion and uPA expression/ activity in the studied cell lines. A similar effect of ADM on NO production also can be observed in primary EVCTs. On the other hand, NO donors mimic the biological activities of ADM on EVCT cell lines. NO has also been shown to induce uPA production in endothelial cells [56] .
The mechanism of action of ADM on the expression of NOS in EVCT remains unknown. In cardiac and endothelial cells, ADM acts through its G protein-coupled receptor system to increase cyclic adenosine monophosphate (cAMP) production [10] , which may enhance NOS expression through two mechanisms, namely enhancement of the binding of transcription factors such as cAMP-responsive element binding protein on NOS promoters [57, 58] , and increase in the stability of NOS mRNA [57, 59] . Previous study had shown that cAMP may either enhance or inhibit NO expression depending on its concentration [60] , suggesting that there is a delicate balance between the stimulatory and inhibitory roles of cAMP. Consistent with our results, the stimulatory action of ADM on the trophoblast invasion was loss at a concentration .10 nM. Whether the high ADM concentration would shift the balance in favor of inhibition of trophoblast invasion via cAMP is worth further investigation.
The rapid action of ADM on induction of NO production in EVCTs suggests that ADM may upregulate NOS activity. There are at least two known mechanisms for eNOS activation by ADM. ADM can trigger the activation of phosphatidylinositol 3-kinase and protein kinase B/v-akt murine thymoma viral oncogene homolog (Akt) signaling pathway, resulting in the phosphorylation and increased activity of NOS [61] . Another possibility is that ADM upregulates intracellular Ca 2þ to increase the NOS activity [62] . For example, ADM treatment of rat hypothalamic neurons caused a rapid transient increase in Ca 2þ together with NO production in the first 5 min [63] . S-nitrosylation involves covalent attachment of an NO group to a cysteine thiol side chain. Protein S-nitrosylation can either activate or inactivate protein function, depending on the protein nitosylated [29] . For example, S-nitrosylation activates MMP9 activities in trophoblasts [64] . ADM treatment of JEG-3 cells significantly increased protein S-nitrosylation. By using the biotin-switch method, we provided the first evidence that uPA could be S-nitrosylated by NO. GSNO treatment of purified uPA further demonstrated that S-nitrosylated uPA had a higher enzyme activity. The question of how S-nitrosylation increases uPA activity is still unknown. There are various mechanisms by which S-nitrosylation can upregulate enzyme activities, such as promotion of autophosphorylation [65] , stabilization of enzyme structure [66] , and direct activation of pro-enzyme [67] .
In conclusion, the current investigation demonstrates that ADM modulates the invasion of EVCT cell lines by regulating uPA expression and activity through NO signaling pathway. However, as most of the study used cultured cell lines which may not possess all the characteristics of their parental cells in vivo, the present observations need to be verified using primary trophoblast cells. Pre-eclampsia, intrauterine growth restriction, and choriocarcinoma are associated with perturbed trophoblast invasion and changes in ADM, ADM receptor, or NOS activity/expression [68] [69] [70] [71] [72] [73] . It remains to be determined whether ADM or NO donors can be used to enhance invasion in complicated pregnancies due to inadequate invasion.
